Bosentan alleviates the pro-fibrotic phenotype of lung scleroderma fibroblasts: Implications for treatment of scleroderma.

Míreanna comhchosúla

• Bosentan attenuates the profibrotic gene expression profile of lung fibroblasts in scleroderma
  de réir: Shiwen, X, et al.
  Foilsithe / Cruthaithe: (2006)
• Effects of bosentan on collagen type I synthesis on in vitro culture of scleroderma skin fibroblasts
  de réir: S. Soldano, et al.
  Foilsithe / Cruthaithe: (2011-01-01)
• Successful Treatment with Bosentan of Lower Extremity Ulcers in a Scleroderma Patient
  de réir: Alix Naert, et al.
  Foilsithe / Cruthaithe: (2013-01-01)
• CTGF overexpressing mice: a model for human scleroderma
  de réir: Sonnylal, S, et al.
  Foilsithe / Cruthaithe: (2006)
• Bosentan Does Not Affect Renal Resistive Index in Scleroderma/Systemic Sclerosis Patients
  de réir: Emma Di Poi, et al.
  Foilsithe / Cruthaithe: (2023-11-01)